CFTR and cystic fibrosis: This approach has been already tested in canine models for the treatment of Duchenne Muscular Dystrophy (Amoasii et al., 2018; Lim et al., 2018), and despite it has not been tested in animal models for the treatment of CF, it has been found effective in correcting CFTR defects (Hsu et al., 2014).